Salmon Lice Vaccines in Aquaculture Welfare

Sea lice are the leading parasitic threat to farmed Atlantic salmon, and vaccine development offers a welfare-friendly alternative to chemical treatments.

Key Facts

Sea lice cause open wounds, fin damage, scale loss, and immune suppression in farmed salmon
A single adult female louse can produce over 1,000 offspring per season
Chemical treatments like hydrogen peroxide cause acute stress and occasional mortality in salmon
Mechanical delousing using warm water or lasers causes measurable physiological stress
Vaccine research is ongoing but no fully effective commercial salmon louse vaccine exists yet
Sea lice cost the global salmon industry over $1 billion annually in treatments and losses

Welfare Considerations

Sea lice infestations represent one of the most significant welfare challenges in salmon aquaculture. The parasites cause painful lesions and chronic immune activation, while control methods — chemical baths, laser systems, and freshwater treatments — each carry their own welfare costs. Effective vaccination would eliminate both the infestation harm and the treatment stress, making it arguably the highest-impact welfare advance available for farmed salmon. Supporting investment in this research area has major potential welfare benefits at scale.

What You Can Do

Support aquaculture welfare research organizations working on parasite management
Choose salmon certified by welfare-conscious standards that assess lice burden limits
Advocate for aquaculture regulations that mandate welfare monitoring including lice counts
Reduce salmon consumption or switch to plant-based omega-3 sources if welfare concerns persist